Activity of caffeic acid phenethyl ester in Caenorhabditis elegans

Multistate Point-Prevalence Survey of Health Care–Associated Infections

(2014) Shelley S. Magill et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials

(2012) D. R. Andes et al.   CLINICAL INFECTIOUS DISEASES

The role of mycelium production and a MAPK-mediated immune response in theC. elegans-Fusariummodel system

(2012) Maged Muhammed et al.   MEDICAL MYCOLOGY

Antifungal Activity of Microbial Secondary Metabolites

(2011) Jeffrey J. Coleman et al.   PLoS One

Candida albicans Infection of Caenorhabditis elegans Induces Antifungal Immune Defenses

(2011) Read Pukkila-Worley et al.   PLoS Pathogens

Characterization of Plant-Derived Saponin Natural Products againstCandida albicans

(2010) Jeffrey J. Coleman et al.   ACS Chemical Biology

The effect of caffeic acid phenethyl ester on the functions of human monocyte-derived dendritic cells

(2009) Li-Chieh Wang et al.   BMC IMMUNOLOGY

Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36

(2009) Terry K. Means et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Identification of Antifungal Compounds Active against Candida albicans Using an Improved High-Throughput Caenorhabditis elegans Assay

(2009) Ikechukwu Okoli et al.   PLoS One

CAPE (caffeic acid phenethyl ester)-based propolis extract (Bio 30) suppresses the growth of human neurofibromatosis (NF) tumor xenografts in mice

(2008) M. Demestre et al.   PHYTOTHERAPY RESEARCH